American Century Companies’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.5M Buy
1,087,523
+94,795
+10% +$2.52M 0.02% 977
2025
Q4
$24.7M Sell
992,728
-682,769
-41% -$17.2M 0.01% 1059
2025
Q3
$42.7M Sell
1,675,497
-546,598
-25% -$13.5M 0.02% 784
2025
Q2
$53.9M Sell
2,222,095
-334,926
-13% -$7.81M 0.03% 642
2025
Q1
$64.8M Sell
2,557,021
-122,607
-5% -$3.21M 0.04% 489
2024
Q4
$71.1M Buy
2,679,628
+75,245
+3% +$2.04M 0.04% 466
2024
Q3
$75.4M Buy
2,604,383
+61,511
+2% +$1.79M 0.04% 431
2024
Q2
$71.1M Sell
2,542,872
-514,840
-17% -$14.2M 0.04% 422
2024
Q1
$84.9M Sell
3,057,712
-63,869
-2% -$1.77M 0.05% 377
2023
Q4
$89.9M Sell
3,121,581
-250,527
-7% -$7.57M 0.06% 337
2023
Q3
$112M Sell
3,372,108
-306,013
-8% -$10.8M 0.09% 260
2023
Q2
$135M Buy
3,678,121
+379,487
+12% +$14.8M 0.1% 235
2023
Q1
$134M Sell
3,298,634
-1,915,362
-37% -$82.7M 0.11% 230
2022
Q4
$267M Buy
5,213,996
+1,491,342
+40% +$71.5M 0.22% 117
2022
Q3
$163M Buy
3,722,654
+1,029,069
+38% +$50M 0.14% 166
2022
Q2
$141M Buy
2,693,585
+345,697
+15% +$17.6M 0.12% 202
2022
Q1
$122M Sell
2,347,888
-467,141
-17% -$24.2M 0.08% 259
2021
Q4
$166M Buy
2,815,029
+276,896
+11% +$13.7M 0.11% 211
2021
Q3
$109M Sell
2,538,133
-1,688,022
-40% -$74.8M 0.07% 275
2021
Q2
$165M Sell
4,226,155
-649,492
-13% -$25.3M 0.11% 192
2021
Q1
$177M Buy
4,875,647
+1,391,990
+40% +$49.4M 0.13% 186
2020
Q4
$128M Sell
3,483,657
-3,818,617
-52% -$140M 0.1% 234
2020
Q3
$254M Sell
7,302,274
-5,170,134
-41% -$181M 0.23% 116
2020
Q2
$387M Sell
12,472,408
-81,188
-0.6% -$2.76M 0.37% 61
2020
Q1
$389M Sell
12,553,596
-7,978,389
-39% -$272M 0.46% 44
2019
Q4
$763M Sell
20,531,985
-5,285,537
-20% -$188M 0.73% 17
2019
Q3
$880M Buy
25,817,522
+13,562,265
+111% +$493M 0.88% 13
2019
Q2
$504M Sell
12,255,257
-876,483
-7% -$34.8M 0.5% 36
2019
Q1
$529M Sell
13,131,740
-1,416,876
-10% -$56.7M 0.54% 30
2018
Q4
$603M Sell
14,548,616
-3,317,606
-19% -$138M 0.69% 18
2018
Q3
$747M Sell
17,866,222
-3,268,329
-15% -$126M 0.73% 15
2018
Q2
$727M Sell
21,134,551
-1,258,195
-6% -$43M 0.73% 15
2018
Q1
$754M Sell
22,392,746
-1,364,296
-6% -$46.9M 0.77% 14
2017
Q4
$816M Buy
23,757,042
+7,548,634
+47% +$257M 0.81% 14
2017
Q3
$549M Buy
16,208,408
+730,034
+5% +$23.5M 0.56% 29
2017
Q2
$493M Sell
15,478,374
-3,076,679
-17% -$97M 0.51% 36
2017
Q1
$602M Sell
18,555,053
-2,993,806
-14% -$94.4M 0.63% 19
2016
Q4
$664M Sell
21,548,859
-9,431,385
-30% -$288M 0.72% 15
2016
Q3
$996M Sell
30,980,244
-2,495,719
-7% -$83.5M 1.09% 7
2016
Q2
$1.12B Sell
33,475,963
-1,841,731
-5% -$58.8M 1.27% 5
2016
Q1
$993M Buy
35,317,694
+4,883,839
+16% +$140M 1.16% 5
2015
Q4
$932M Sell
30,433,855
-769,958
-2% -$24.2M 1.09% 6
2015
Q3
$930M Buy
31,203,813
+6,336,005
+25% +$203M 1.14% 7
2015
Q2
$791M Buy
24,867,808
+3,136,905
+14% +$102M 0.89% 9
2015
Q1
$717M Buy
21,730,903
+101,187
+0.5% +$3.22M 0.8% 10
2014
Q4
$639M Sell
21,629,716
-1,254,323
-5% -$36M 0.72% 14
2014
Q3
$642M Sell
22,884,039
-208,531
-0.9% -$5.85M 0.75% 14
2014
Q2
$650M Buy
23,092,570
+252,737
+1% +$7.2M 0.74% 15
2014
Q1
$696M Buy
22,839,833
+173,014
+0.8% +$5.16M 0.82% 13
2013
Q4
$659M Sell
22,666,819
-437,934
-2% -$12.7M 0.78% 15
2013
Q3
$629M Buy
23,104,753
+573,917
+3% +$15.6M 0.79% 14
2013
Q2
$599M Buy
+22,530,836
New +$623M 0.79% 16

Other funds holding PFE

American Century Companies's PFE Position: Q1 2026 in Review

American Century Companies increased its Pfizer (PFE) stake by 9.5% in Q1 2026, buying an estimated $2.52M and bringing the position to 1,087,523 shares worth $30.5M. The position accounts for 0.02% of the portfolio, ranked #977.

American Century Companies first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.12B in Q2 2016. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • American Century Companies held 1,087,523 shares of Pfizer worth $30.5M as of Q1 2026.
  • American Century Companies bought 94,795 Pfizer shares in Q1 2026, an estimated $2.52M.
  • Pfizer made up 0.02% of American Century Companies's portfolio in Q1 2026, its #977 holding.
  • American Century Companies first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • American Century Companies's Pfizer position peaked at $1.12B in Q2 2016.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.